“Celastrol” for Osteoporosis
DOI:
https://doi.org/10.5281/zenodo.6374497Keywords:
Celastrol, OsteoporosisAbstract
“Celastrol” for Osteoporosis
References
Johnell O, Kanis JA. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int 2006;17(12):1726-33.
Sözen T, Özışık L, Başaran NÇ. An overview and management of osteoporosis. Eur J Rheumatol 2017;4(1):46-56.
Chen LR, Ko NY, Chen KH. Medical Treatment for Osteoporosis: From Molecular to Clinical Opinions. Int J Mol Sci 2019;20(9):2213.
Wang ZQ, Li JL, Sun YL, Yao M, Gao J, Yang Z, Shi Q, Cui XJ, Wang YJ. Chinese herbal medicine for osteoporosis: a systematic review of randomized controlled trails. Evid Based Complement Alternat Med 2013;2013:356260.
Yang F, Xu MR, Yang MF, Lam CH, Lau MT, Yuan ZH. Patterns of the use of traditional Chinese medicines in the treatment of osteoporosis. Chin. J. Rehabil. Med 2005;9(31):203-205.
Venkatesha SH, Moudgil KD. Celastrol and its role in controlling chronic diseases. Antiinflammatory nutraceuticals and chronic diseases. USA: Springer;2016:267-289.
Law S, Leung A.W, Xu C. Is the traditional Chinese herb, "Celastrol" effective to combat COVID-19? J. Mater. Environ. Sci 2020;11(8):1205-1208.
Xi J, Li Q, Luo X, Wang Y, Li J, Guo L, Wu G. Celastrol inhibits glucocorticoid induced osteoporosis in rat via the PI3K/AKT and Wnt signaling pathways. Mol Med Rep 2018;18(5):4753-4759.
Cascão R, Vidal B, Jalmari Finnilä MA, Lopes IP, Teixeira RL, Saarakkala S, Moita LF, Fonseca JE. Effect of celastrol on bone structure and mechanics in arthritic rats. RMD Open 2017;3(2):e000438.
Liu XD, Cai F, Zhang Y, Yang A, Liu L. Celastrol, an NF-κB inhibitor, ameliorates hypercalciuria and articular cartilage lesions in a mouse model of secondary osteoporosis. J. Pharmacol. Sci 2016;130(4):204-211.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Siukan Law, Dawn Chingtung Au
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles in BioMedicine and Surgery are published under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International license. Full text of Attribution-NonCommercial-NoDerivatives 4.0 International license can be viewed at https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode.